Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Research and development spending
3Y CAGR
+8.2%/yr
vs -9.6%/yr prior
5Y CAGR
+7.6%/yr
Consistent
Acceleration
+17.8pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $17.73M | +42.2% |
| 2024 | $12.47M | -20.6% |
| 2023 | $15.71M | +12.3% |
| 2022 | $13.99M | -58.8% |
| 2021 | $33.91M | +175.3% |
| 2020 | $12.32M | -31.4% |
| 2019 | $17.95M | -14.3% |
| 2018 | $20.95M | -12.8% |
| 2017 | $24.02M | -33.5% |
| 2016 | $36.11M | - |